LenioBio – ReciBioPharm

LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production

LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a global contract development and manufacturing organization (CDMO), to scale up protein manufacturing capabilities and expedite vaccine production. 

Read Article
1080x1080 beige - b

Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response

LenioBio and Touchlight announce supply agreement to leverage rapid enzymatic doggybone DNA to accelerate vaccine development and manufacture in the context of LenioBio's CEPI grant.

Read Article
1080x1080 LenioBio x labscoop USPs v2

Labscoop and LenioBio Announce Strategic Partnership to Enhance Access of Scalable Cell-Free Protein Synthesis Technology Across North America.

Labscoop LLC, announce a strategic partnership to bring LenioBio’s  line of cutting-edge products and services to Labscoop Marketplace users and the North American market more broadly.

Read Article
CEPI+logo-d7dac039-1920w

Plant-Based ALiCE® Technology Could Shave Weeks Off Vaccine Production

LenioBio GmbH has received CEPI funding of up to US $2 million to provide preclinical proof-of-concept that their commercially available, plant-based, and cell-free technology can produce proteins for use in clinical trials testing vaccines against epidemic and pandemic threats in 20-40 days.

Read Article
Kathrin-Knauf-LenioBio-Chief-Technology-Officer-1920w

LenioBio Appoints CTO and CCO to Spearhead Growth and Innovation

LenioBio today announced the appointments of Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.

Read Article
Hugh_Watson_CFO-9a2c502a-4164dc9b-1920w

LenioBio appoints Hugh Watson as Chief Financial Officer

LenioBio appoints Hugh Watson as Chief Financial Officer as of January 1st, 2024. Hugh brings with him a wealth of experiene and strategic financial insight.

Read Article
André+Porträt+2-1920w

LenioBio announces new CEO

LenioBio announces André Goerke as new CEO

Read Article
A1pY2d5t_400x400-1920w

LenioBio announces appointment of Professor Daniel Bracewell to its Scientific Advisory Board.

Prof. Bracewell is appointed member of LenioBio's Scientific Advisory Board.

Read Article
MicrosoftTeams-image-1920w

LenioBio announces appointment of new Chief Business Officer to Leadership Team

Jasper Levink joined LenioBio in January 2022 as Lead of the Business Unit...

Read Article
522_+LenioBio+instagram+(1)-1920w (1)

LenioBio reaches industrial-scale with its high-yield eukaryotic platform for cell-free protein synthesis.

LenioBio reaches industrial-scale with its high-yield eukaryotic platform for cell-free protein synthesis.

Read Article
PepperlogoRGB_jpeg-1920w

A breakthrough in biopharmaceutical protein production; LenioBio announces a new proprietary cell line devoid of plant glycans.

LenioBio generated a novel plant glycan knockout cell line that will increase the versatility and flexibility...

Read Article
Featured-Eurostars-1920w

LenioBio awarded prestigious Eurostars grant

LenioBio GmbH announced today that the company has been awarded a grant...

Read Article
EXTENSIONNES-3e81a514-2880w

LenioBio closes its Series-A Extension round and strengthens its Board of Directors.

LenioBio closed its Series-A Extension round with a total investment volume of €11.5 million and strengtheneds its board of directors.

Read Article
800px-Flag_of_Europe.svg-1920w

LenioBio Wins Prestigious Horizon 2020 SME/2 Grant

The company has been awarded a grant to accelerate the scale-up of its proprietary protein expression platform ALiCE.

Read Article
LenioBio+GmbH-1920w

LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology

New Scientific Advisory Board composed of experts within the field of Biotechnology.

Read Article
Fraunhofer-Institut+für+Molekularbiologie+und+Angewandte+Oekologie+IME-1920w

LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries through a License Agreement


LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries through a License Agreement

Read Article
License+Agreement+with+Dow+AgroSciences+-+Image-1920w

Protein Science to Advance through LenioBio and Dow AgroSciences License Agreement

Protein Science to Advance through LenioBio and Dow AgroSciences License Agreement

Read Article

Stay Updated

Get Fast And Cheaper US Delivery

No results